Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 - Test2 - elhamkhani - TriplyDB

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

http://www.wikidata.org/entity/Q27644478

about

Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development bNAber: database of broadly neutralizing HIV antibodies "Rules of Engagement" of Protein-Glycoconjugate Interactions: A Molecular View Achievable by using NMR Spectroscopy and Molecular Modeling Harnessing the protective potential of HIV-1 neutralizing antibodies The HIV glycan shield as a target for broadly neutralizing antibodies Recent strategies targeting HIV glycans in vaccine design Structural insights on the role of antibodies in HIV-1 vaccine and therapy Nonhuman primate models for HIV/AIDS vaccine development Designing synthetic vaccines for HIV Antibody responses to envelope glycoproteins in HIV-1 infection HIV-1 neutralizing antibodies: understanding nature's pathways Host-pathogen interaction in HIV infection HIV-1 envelope glycoprotein structure Antibodies in HIV-1 vaccine development and therapy HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection HIV broadly neutralizing antibody targets Catching HIV 'in the act' with 3D electron microscopy A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen Computational Refinement and Validation Protocol for Proteins with Large Variable Regions Applied to Model HIV Env Spike in CD4 and 17b Bound State.Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Cross-neutralization of influenza A viruses mediated by a single antibody loop Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans Structural Basis for Highly Effective HIV-1 Neutralization by CD4-Mimetic Miniproteins Revealed by 1.5 Å Cocrystal Structure of gp120 and M48U1 Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies

P2860

Q21558777-754F68AD-02E5-4084-9A50-71E5C24B62EA Q24567758-43CF038E-D251-43CF-B90A-A43BD15A3350 Q26740050-E683E7BD-F0B6-487F-A605-ACBCCC17ED47 Q26766153-3D068915-4511-44E4-8F7A-C96BD22D403D Q26786540-E3229914-AA08-4133-802E-40AA6E6D4217 Q26823603-3300DB9B-26EA-4F72-BE46-A76C9698B95C Q26829461-38D53C51-E7F4-4C0C-9121-CD907D4E69C2 Q26861148-B0933EA5-14AC-45B9-AD9E-954F6CE533D5 Q26862617-780E09C5-4BCA-4F1C-80DF-C73ADAFB8C0D Q26991572-3830AD0D-DA00-4817-8A40-44C39A51E46C Q27000480-6DF8A4CA-860D-4235-AFC6-C833E47C1E37 Q27009024-F4E7DB88-68C6-45A8-901A-75FAA912F7A5 Q27011248-4FF20CF3-2C75-41BC-AA47-ED095B124D64 Q27011574-9663AB2B-31C3-4F2B-8BA0-8E827F2F2186 Q27022055-4FC4ACC9-929F-4F7F-9860-F303B5CFFE85 Q27022652-4F298017-9C3E-4255-8724-16F134FFB930 Q27026662-6A6202E8-75E5-45D4-B51E-21DDE8B57F51 Q27026806-C76321FE-8145-4F71-8A2C-464DB985FAB8 Q27302081-1902B7BB-043F-4FFD-8C05-560A03B1BB32 Q27303608-CB4E4FF6-7272-42C6-866F-BBD338FD57D2 Q27320687-31BA6F1F-6B7F-4A1B-848B-E7704B8555EC Q27322437-A2C9BF63-5FF6-4CE4-B55A-925AD2B51C78 Q27333522-63E4D1F8-2FEC-443B-A44E-48BF81B85E15 Q27644383-634C68D8-952F-42F4-A29B-B724352AAB81 Q27644515-1620C21E-DACD-4C97-8A92-0B21BFBF219F Q27644634-E45D3B66-8ADA-441E-B36B-B763CD05C4A2 Q27673206-E0673E0A-ADD6-46E9-8CA5-7CD64FD1301D Q27674878-67EB1198-0676-4090-B4CF-CE5F92A5CEC6 Q27675879-515B5F9B-9DEE-4D5E-9AD9-9134C591B0DE Q27676728-37E9A8B6-FB95-479C-9B54-0F5D91ED20E7 Q27677941-58709E85-BC10-410B-B7BA-B83413261E20 Q27678062-B99A4EF5-73B5-495A-81E8-88E3C6DEC32D Q27678297-06DEA91A-5750-4B39-B301-8F392C1DE2B4 Q27678306-6E77C18D-30E5-456A-898E-3D42828AADE5 Q27678312-E6C721D7-8BA1-433E-80B3-5F23BAFEA00F Q27679280-4D4A5CAF-B13E-41FA-9BC5-A36FF2332DED Q27680496-99575A4D-BF11-4A17-8A40-EAF5B0166283 Q27680497-97F892A6-02A6-4515-B3E0-7ECE823072C0 Q27680499-75B0512F-FC9D-4BD6-A418-490ACD6DBBBD Q27680688-2471601D-BEB6-45D3-BBA3-2362B359BBB6

P2860

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

http://www.wikidata.org/entity/Q27644478

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@ast

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@en

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@nl

type

label

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@ast

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@en

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@nl

prefLabel

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@ast

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@en

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@nl

P1433

Q27644478-F65D3FA7-5944-4221-8CBB-B069760AECE0

P1476

Q27644478-C3859573-E916-4F6A-BFE5-5BB9F2579B03

P2093

Q27644478-047CA4D3-F945-4BC7-A5DB-FDFD61233E87

Q27644478-07B192AC-103D-4735-B55D-00859FB70068

Q27644478-07B3D7D4-1C0E-44FB-9610-650209A13B14

Q27644478-09FB3FA2-7520-4FD0-8182-A31F11B2FADF

Q27644478-2839EDD9-228B-47AD-A448-CD0355F3778A

Q27644478-2917A338-EFB5-4805-9A82-DCE6E9EF799C

Q27644478-312762F0-F972-4689-AEEB-E886EEB792CD

Q27644478-418CCBC5-14AC-482F-9224-4A3067DECC03

Q27644478-43931E37-918A-47DB-A68E-038181179C36

Q27644478-62533DB9-8085-4974-A4A5-2AA45CDF3517

P2860

Q27644478-03953630-9E39-4DA6-8382-FB354FFB6996

Q27644478-0894EC23-991A-4F15-B6A7-DD7055187C43

Q27644478-0BA1C285-5005-4B28-9F7E-78D29D4E4587

Q27644478-0BF76B51-3ADC-41D7-8589-1968A7E2EAA5

Q27644478-1133E8EB-183E-4385-801C-76A8530E5702

Q27644478-129E7DA8-1669-4F62-B696-39150D126C71

Q27644478-13928E80-4368-4CCB-83C8-9F4CDA186D50

Q27644478-148A7B34-5494-4235-9C9F-9C4DEB3BAD82

Q27644478-16B5ABFA-F31E-4137-B068-EE9A463FBF72

Q27644478-1771FCE8-2C45-49D6-8713-2F78A2B49348

P2888

Q27644478-95B4ADB9-B6EC-47DF-B9E9-DC20FA5800C2

P304

Q27644478-1120CAF7-A180-438D-B695-429DD7B90813

P31

Q27644478-01543BE6-80BD-4A97-B084-CE9B60908130

P3181

Q27644478-43DAB390-179D-4A6F-A3AC-24C354702373

P356

Q27644478-7BA14E25-F6CB-4556-9CFC-55C69D354D62

P407

Q27644478-6FF5BAE4-E3B5-4EBE-89A0-B8196FEFC8EE

P433

Q27644478-2348A566-782A-4D0A-B626-4CBF6F3D74B4

P478

Q27644478-38307406-BEB9-4F35-B0D3-3C49B4056EC9

P50

Q27644478-253EDE99-FB25-49A5-9E25-4294F6A71722

Q27644478-2544607D-484D-4494-BC8D-FA572307C4C3

Q27644478-372A9D84-C6F2-43E9-BEB8-63146BA43103

Q27644478-624E9818-8D2D-45BB-A1E1-011C723E5BA8

Q27644478-69A07B6A-9F29-4807-A246-F2F109644E99

Q27644478-8519B861-129E-475E-8E6D-E927A76AC82B

Q27644478-8C0157F7-ABA4-4CD0-A4F4-58A4C593B0DA

Q27644478-9E712C18-E29F-49B2-A585-E80524C6EFFC

Q27644478-B2BC2C98-3FE6-4339-8979-804A1455FA73

Q27644478-D60168A6-3A22-484C-8E0D-EE3BFE92B66F

P577

Q27644478-4DFAE4E3-D487-4456-AB8B-DE6E7A3357F2

P5875

Q27644478-61944D63-5FC7-4AA3-A1CE-5A0B0DB25709

P6179

Q27644478-CB9C0105-4A1D-4B6F-894E-35F245C43E73

P698

Q27644478-90BEBE7A-F9B1-444C-9D06-81C1440AAA25

P921

Q27644478-06300CFC-A1E2-434A-A00E-33C83A551C40

Q27644478-4B0E298A-DF2D-4D85-9BE1-222E913A31E0

Q27644478-610FBD3B-6BF3-4E22-8A68-717ADAC9F183

Q27644478-68556BB3-E429-4FE2-B814-799E9565E419

Q27644478-DE262205-3988-4DC5-9BA6-B4135BFFAB10

P932

Q27644478-A203A88A-DFFE-47C2-86E6-42DED7E39240

P3181

P356

P1433

P1476

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

@en

P2093

Andrew B Ward

http://www.w3.org/2001/XMLSchema#string

Baoshan Zhang

http://www.w3.org/2001/XMLSchema#string

Carole A Bewley

http://www.w3.org/2001/XMLSchema#string

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Devan Diwanji

http://www.w3.org/2001/XMLSchema#string

Doyung Lee

http://www.w3.org/2001/XMLSchema#string

Gwo-Yu Chuang

http://www.w3.org/2001/XMLSchema#string

James Arthos

http://www.w3.org/2001/XMLSchema#string

Jared Orwenyo

http://www.w3.org/2001/XMLSchema#string

Jason S McLellan

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

Analytical molecular surface calculation

Structural definition of a conserved neutralization epitope on HIV-1 gp120

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure

Three-dimensional structure of the Fab from a human IgM cold agglutinin

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

Designed protein G core variants fold to native-like structures: Sequence selection by ORBIT tolerates variation in backbone specification

P2888

P304

336-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

415010

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE10696

http://www.w3.org/2001/XMLSchema#string

P407

P433

7377

http://www.w3.org/2001/XMLSchema#string

P478

480

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Philippe Julien

Ivelin S. Georgiev

Stephanie Moquin

Ian Andrew Wilson

P577

2011-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51825423

http://www.w3.org/2001/XMLSchema#string

P6179

1016437859

http://www.w3.org/2001/XMLSchema#string

P698

22113616

http://www.w3.org/2001/XMLSchema#string

P921

alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp

alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc

N(4)-{alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc}

P932

3406929

http://www.w3.org/2001/XMLSchema#string